Literature DB >> 8002645

Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin. Involvement of protein kinase C.

G F Webster1, S M Toso, L Hegemann.   

Abstract

BACKGROUND AND
DESIGN: Granulomatous inflammation is a common component of many diseases. In this study the ability of commonly used antibiotics to inhibit an in vitro model of granuloma formation were studied. The effect of protein kinase C inhibition in this system was also investigated.
RESULTS: Ampicillin, cephalothin, metronidazole, rifampin, isoniazide, erythromycin, and clindamycin were inactive in inhibiting granuloma formation. Tetracycline, doxycycline, minocycline, and ciprofloxacin produced dose-dependent inhibition of the granuloma model in concentrations between 10(-4) and 10(-6) mol/L. The approximate order of descending potency was doxycycline equals minocycline greater than tetracycline greater than ciprofloxacin. The same drugs were tested for the ability to inhibit protein kinase C. Drugs inactive in the granuloma model had no effect on protein kinase C activity. The tetracyclines and ciprofloxacin all caused a dose-dependent inhibition of protein kinase C activity in the same order of relative potency as was found for inhibition of granuloma formation.
CONCLUSIONS: These data demonstrate a previously unappreciated activity of the tetracyclines and ciprofloxacin. Inhibition of granuloma formation helps to account for the activity of these drugs in the severest forms of inflammatory acne.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8002645

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  19 in total

Review 1.  Tetracyclines and pain.

Authors:  Leandro F S Bastos; Antônio C P de Oliveira; Linda R Watkins; Márcio F D Moraes; Márcio M Coelho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-27       Impact factor: 3.000

2.  In vitro modulation of epidermal inflammatory cytokines (IL-1 alpha, IL-6, TNF alpha) by minocycline.

Authors:  P Célérier; P Litoux; B Dréno
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

Review 3.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

4.  Antibiotics modulate vaccine-induced humoral immune response.

Authors:  P C Woo; H W Tsoi; L P Wong; H C Leung; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Authors:  John S Barbieri; Ketaki Bhate; Kathleen P Hartnett; Katherine E Fleming-Dutra; David J Margolis
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

6.  Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?

Authors:  Eishi Miyazaki; Masaru Ando; Tetsujiro Fukami; Shin-Ichi Nureki; Yoshinobu Eishi; Toshihide Kumamoto
Journal:  Clin Rheumatol       Date:  2008-05-06       Impact factor: 2.980

7.  A novel non-antibacterial, non-chelating hydroxypyrazoline derivative of minocycline inhibits nociception and oedema in mice.

Authors:  L F S Bastos; A Angusti; M C Vilaça; L A Merlo; E B Nascimento; L T S Rocha; A M Godin; A G R Solano; S Jarussophon; E A Nunan; Y Konishi; M M Coelho
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

8.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines.

Authors:  Teresa Krakauer; Marilyn Buckley
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 10.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.